IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?. Mediterr J Hematol Infect Dis [Internet]. 2021 Oct. 29 [cited 2026 Apr. 18];13(1):e2021062. Available from: https://www.mjhid.org/mjhid/article/view/4702